| | |
Professor Marion Kiechle
Director of the Gynaecology Department, ‘rechts der Isar’ Hospital, Munich University of Technology
Professor Marion Kiechle, a specialist of national and international renown based at Munich University of Technology’s ‘rechts der Isar’ Hospital, provides top-rate treatment for women suffering from gynaecological problems.
Professor Kiechle has received numerous awards and prizes, most recently the Order of Merit of the Federal Republic of Germany, for her medical research work in the field of gynaecological oncology. She has held the chair for gynaecology and obstetrics at Munich University of Technology and been medical director of the Gynaecology Department at the ‘rechts der Isar’ Hospital since October 2000. In addition to this, she chairs the bioethics commission of the Bavarian State Government, is deputy chairperson of the German Federal Government’s central ethics commission on stem cell research and is a member of the university senate.
Treatment focuses on operative and nonoperative therapy for cancers in women.
The interdisciplinary breast centre at Munich University of Technology’s ‘rechts der Isar’ Hospital has been officially certified and recertified by the German Cancer Society and the German Society for Senology, meeting and exceeding the highest quality standards.
“As a certified breast centre, we can offer our patients even better and more comprehensive care,” says Professor Kiechle, speaking on behalf of the centre. Professor Kiechle and her team treat 400 new cases of breast cancer at the Breast Centre of the ‘rechts der Isar’ Hospital every year
Interdisciplinary approach to patients’ wellbeing
“Thanks to scientific studies, we have known since the end of the 1990s that a therapy decision made by an interdisciplinary team improves gynaecological cancer patients’ survival rates.” That is why the Gynaecology Department holds regular interdisciplinary conferences in which various experts – including radiologists, radiotherapists, specialists in nuclear medicine, general surgeons, internalists/oncologists, anaesthetists and pathologists – meet to discuss test results and therapy options for the patient.
Early diagnosis, prompt therapy
The earlier a patient goes to her doctor, the earlier a problem can be detected and treated and the better the prognosis. Professional diagnosis of breast tumours in women, however, requires the expertise of highly experienced specialists working in mammography screening centres. “It’s how the Breast Centre is able to treat three quarters of women without a mastectomy,” explains Professor Kiechle. This is one of the highest rates in Germany and is comparable with the success rates of the world’s best cancer centres."
Professor Kiechle’s department, in which she often sees patients herself, specialises in specific areas such as hereditary breast cancer and ovarian cancer, lymphatic therapy and psychological counselling.
The benefits of research
The Gynaecology Department participates in clinical studies and basic research both in Germany and abroad, producing outstanding results that are reflected in the individual treatment programmes. There is a clinical research group (led by Professor M. Schmitt) and a gynaecological tumour genetics group (led by Professor A. Meindl). Just recently, researchers at the university discovered a risk gene: “This is extremely useful for diagnosing cases of hereditary breast and ovarian cancer at an early stage,” says Professor Kiechle. Around 5 per cent of patients have inherited a gene mutation from their mother or father, and around 85 per cent of these genetically predisposed women are actually diagnosed with breast cancer at an early age. Women from such families should therefore undergo genetic testing early on.